jmp pro version 15.0 (SAS institute)
SAS institute is a verified supplier 
90
Structured Review
SAS institute
jmp pro version 15.0
Jmp Pro Version 15.0, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jmp+pro+version+15%2E0/jmp+version+11+0/pm39906003-54-5-9
Average 90 stars, based on 1 article reviews
Jmp Pro Version 15.0, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jmp+pro+version+15%2E0/jmp+version+11+0/pm39906003-54-5-9
Average 90 stars, based on 1 article reviews
jmp pro version 15.0 - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Comparative analysis of oncological outcomes between trimodal therapy and radical cystectomy in muscle-invasive bladder cancer utilizing propensity score matching. Article Snippet: Statistical analyses were performed using Article Title: Comparative Efficacy of Avelumab Maintenance Therapy Versus Continued Chemotherapy Followed by Pembrolizumab in Metastatic Urothelial Carcinoma With No Progression After 4 Cycles of Chemotherapy: A Retrospective Study Using Propensity Score Matching. Article Snippet: This study compared avelumab maintenance therapy with pembrolizum for treating advanced urothelial carcinoma without progression after 4 prechemotherapy courses.. Using propensity score matching, 27 cases from each treatment showed no significant difference in progression-free survival from the initiation of prechemotherapy–20.7 and 23.3 months for avelumab and pembrolizumab, respectively.. Avelumab requires fewer high-dose glucocorticoid treatments, indicating its potentially safer profile. Article Title: The abundance of regulatory T cell subsets is associated with the clinical outcomes of sarcoidosis. Article Snippet: Objectives: Some patients with sarcoidosis achieve spontaneous remission, whereas others repeatedly experience relapse.. We examined differences in the clinical course of active sarcoidosis according to peripheral blood immunophenotypes before treatment.. Methods: This retrospective study compared peripheral blood immunophenotypes between patients with active sarcoidosis (n = 28) and healthy control subjects (n = 10). Article Title: Resectable Sinonasal Mucosal Melanoma in the Immunotherapy Era: Upfront Surgery vs. Neoadjuvant Therapy. Article Snippet: Objective: We aim to evaluate outcomes for patients with resectable SNMM treated in the immunotherapy era.. Methods: Thirtyseven patients with resectable SNM were identified using our institutional database between 2016 and 2023.. Results: Patients receiving neoadjuvant Ipi/Nivo (46%, n = 17) were more likely to have disease involving the sinuses and/or the skull base (71% vs. 35%, p = 0.05). Article Title: Tretinoin synergistically enhances the antitumor effect of combined BRAF, MEK, and EGFR inhibition in BRAF V600E colorectal cancer. Article Snippet: Statistical analyses were performed in Article Title: Prognostic risk score and index including the platelet-to-lymphocyte ratio and lactate dehydrogenase in patients with metastatic or unresectable urothelial carcinoma treated with immune checkpoint inhibitors. Article Snippet: Background: Avelumab and pembrolizumab are administered after platinum-based chemotherapy for the treatment of metastatic urothelial carcinoma.. We explored the prognostic factors and risk scores for predicting the outcomes of metastatic or unresectable urothelial carcinoma at the start of treatment with immune checkpoint inhibitors.. Methods: This retrospective study included patients with metastatic or unresectable urothelial carcinoma treated with avelumab or pembrolizumab after platinum-based chemotherapy between January 2017 and December 2022. Article Title: Comparative analysis of oncological outcomes between trimodal therapy and radical cystectomy in muscle-invasive bladder cancer utilizing propensity score matching Article Snippet: Statistical analyses were performed using JMP Pro version 15.0 ( Article Title: Tretinoin synergistically enhances the antitumor effect of combined BRAF, MEK, and EGFR inhibition in BRAF V600E colorectal cancer Article Snippet: Statistical analyses were performed in |